Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Everest Medicines Appoints Rogers Yongqing Luo as Chief Executive Officer to Lead Next Stage of Company Growth 2022-09-19 08:00
CellResearch Corporation (CRC) announces positive results of Phase I study for CorLiCyte® 2022-09-17 00:20
New treatment for rare cancer cholangiocarcinoma approved in Australia 2022-09-15 21:00
Shanghai Public Health Clinical Center Completed Patient Enrollment in Clinical Study of PD-L1 Antibody ASC22 (Envafolimab) in Combination with Chidamide for Functional Cure of HIV Infection 2022-09-15 18:10
Hexvix®, A Diagnostic Drug of Asieris, is Now Covered by the 2022 Lecheng Global Specialty Drug Insurance 2022-09-15 17:07
Austar Lifesciences Announces 2022 Interim Results 2022-09-15 16:53
Food Pioneers Sophie's Bionutrients And NewFish Join Forces To Develop Dairy Alternatives From Microalgae 2022-09-15 15:55
GenScript Receives Best Cell & Gene Therapy Supplier Award: Gene Editing and GenScript ProBio Receives Best Biologics CMO Awards: Upstream Processing & Analytical Services 2022-09-15 12:34
ClavystBio launches to translate life sciences breakthroughs into health impact 2022-09-15 10:00
Juniper Biologics Establishes Global Headquarters in Singapore 2022-09-15 09:53
Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences 2022-09-14 20:30
DR CATHERINE MOHR TO JOIN BOARD OF MEDTECH COMPANY AROA BIOSURGERY 2022-09-14 13:05
MD ANDERSON AND RADIOPHARM THERANOSTICS LAUNCH JOINT VENTURE TO DEVELOP NOVEL RADIOPHARMACEUTICALS 2022-09-14 11:09
Data from KN046 in Patients with metastatic NSCLC who failed first line treatment or prior EGFR-TKIs Presented at ESMO 2022 2022-09-14 09:11
GBB Lands USD 15M Pre-Series B Funding Led by Tiger Jade Capital 2022-09-14 09:08
Alphamab Oncology Presents the updated data from Phase 2 Clinical trial on KN046 Combined with platinum doublet chemotherapy as first-line（1L）treatment for NSCLC at ESMO 2022 2022-09-14 09:04
Updated Data Presented for KN026 comboKN046 in 1st Line HER2-Positive Gastric/Gastroesophageal Junction Cancer (GC/GEJ) 2022-09-14 09:01
Antengene Unveils Its First Australian Office to Continue Expanding Global Presence 2022-09-14 08:30
Debiopharm Co-leads a 10M USD Series A Round to Accelerate the Development of Genomic Medicines through Artificial Intelligence 2022-09-14 00:48
TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism 2022-09-13 22:15
1 153 154 155 156 157 452